Cipla informs about press release

10 May 2021 Evaluate

Cipla has informed that it has enclosed press release dated 10th May 2021 titled ‘Cipla Enters into a Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1345.00 -12.80 (-0.94%)
27-Feb-2026 12:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1761.75
Dr. Reddys Lab 1281.15
Cipla 1345.00
Zydus Lifesciences 918.75
Lupin 2303.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×